Latest Articlesddd
Compugen Soaring in an Extremely Down Market The stocks' prices tumbled today except for very few …
NanoViricides and COVID-19 NanoViricides (NNVC), a development-stage nano-biopharmaceutical company with a proprietary and patented drug development …
Treating and Preventing COVID-19 Treating COVID-19, Gilead Sciences With regard to treating patients with COVID-19 we …
The Market Soared Being optimistic about the greatness of American scientific capability does not mean underestimating …
Gilead Sciences to Acquire Forty Seven Gilead Sciences (GILD) and Forty Seven (FTSV) announced today that the companies …
Moderna Therapeutics Among all the firms announcing their interest in working towards designing and producing a …
COVID-19 and the Stock Market The coronavirus that causes COVID-19 is the topic that swallowed all other …
Regeneron, Moderna, and COVID-19 The spread of COVID-19, minute creatures that seem to be trying to …
Gilead and Moderna Stocks Will Outperform Today As stated in Prohost Letter #439 Gilead (GILD) investigational …
Prohost Letter #439 The Coronavirus Outbreak - COVID-19 The news announced that the coronavirus (now known …
CRISPR, Intellia and Editas CRISPR Therapeutics (CRSP) announced revenues of Q4 2019 that beat analysts’ expectations. …
Cassava Sciences From NEWSWIRE we learned that Cassava Sciences (SAVA), a clinical-stage biotechnology company focusing on Alzheimer’s …
Moderna Therapeutics’ Stock Price Soared, Then Gave Back Its Gains in Two Consecutive Days To begin …
Exelixis Announced Results from its CABOMETYX® Combination with Roche's TECENTRIQ® News announced by Exelixis (EXEL) about …
Regeneron Pharmaceuticals Stock is Rallying Regeneron Pharmaceuticals (REGN) stock outperformed last week gaining over $27. The …
Synopsis The way many bloggers are interpreting the quarterly and yearly biotech companies’ financial results seems …
Nektar Therapeutics NKTR-214: A Blockbuster? Nektar Therapeutics (NKTR) published preclinical data of its immuno-oncology candidate NKTR-214 bempegaldesleukin …
As the Market Seems to Soar Our Eyes Are on the Following Biotech Stocks:
Amgen (AMGN): A …
Gilead Stock Is UP Gilead Sciences' (GILD) provided its antiviral experimental drug remdesivir to physicians for …
Vertex Beats Expectations in 2019 Vertex (VRTX) reported fourth-quarter and full-year 2019 financial results yesterday. The …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
